Loading...
•
Dec 31, 2021
Option Care Health Q4 2021 Earnings Report
Option Care Health's financial performance increased due to revenue growth and strategic acquisitions.
Key Takeaways
Option Care Health reported a strong fourth quarter and full year in 2021, marked by a 15.2% increase in net revenue for Q4, reaching $927.2 million, and a net income of $75.5 million. The company's adjusted EBITDA for Q4 grew by 28.3% to $86.8 million. Additionally, Option Care Health completed the acquisition of Wasatch Infusion LLC and announced a definitive agreement to acquire Specialty Pharmacy Nursing Network, Inc.
Net revenue increased by 15.2% to $927.2 million compared to Q4 2020.
Gross profit rose by 15.5% to $212.2 million, representing 22.9% of revenue.
Net income was reported at $75.5 million, or $0.42 earnings per share, including a one-time tax benefit.
Adjusted EBITDA grew by 28.3% to $86.8 million compared to the same period last year.
Option Care Health
Option Care Health
Forward Guidance
For the full year 2022, Option Care Health expects to deliver net revenue between $3.65 billion and $3.85 billion, adjusted EBITDA between $310 million and $330 million, and cash flow from operations of at least $230 million. This guidance does not include the impact of the SPNN acquisition.
Positive Outlook
- Net revenue of $3.65 billion to $3.85 billion is expected.
- Adjusted EBITDA of $310 million to $330 million is anticipated.
- Cash flow from operations is projected to be at least $230 million.
- The company is focused on patient-centered care, serving over a quarter of a million patients in 2021.
- Continued investments are being made to drive future growth.
Challenges Ahead
- Ongoing challenging environment.
- The financial expectations do not include any impact from the acquisition of SPNN.
- Potential variability of material reconciling items.
- Changes in laws and regulations applicable to the business model.
- Changes in market conditions and receptivity to services and offerings.